Product Information

FLUVOXAMINE ER 150 MG CAPSULE is a generic product labeled by Ajanta Pharma USA Inc., priced at $3.6822 per EA under NDC 27241027530. Its NADAC has been published 93 times since Feb 12, 2025.

FDA first approved this application on Oct 17, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FLUVOXAMINE ER 150 MG CAPSULE

Fluvoxamine Maleate
$3.6822per EA

Strength

150 mg/1

NDC

27241027530

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

FLUVOXAMINE MALEATE

Approval Type

Generic (ANDA)

FDA Application

ANDA219055

FDA Approved

10/17/2024

TE Code

AB

On Market Since

10/17/2024

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for FLUVOXAMINE ER 150 MG CAPSULE has been published 93 times since Feb 12, 2025, and over the history we have for it it has declined 25.3%. The table below summarizes its recorded NADAC range and movement.

Current price$3.6822 per EA
All-time high$5.6209 (Aug 13, 2025)
All-time low$3.5197 (Oct 21, 2026)
52-week high$5.2903
52-week low$3.5197
Median price$5.1609
Average price$5.0389
Largest weekly change-13.8% (Sep 23, 2026)
Weeks tracked93
Tracking sinceFeb 12, 2025

Price History

1W

+4.6%

1M

-7.3%

3M

-20.1%

6M

-23.2%

1Y

-25.3%

3Y

N/A

5Y

N/A

All

-25.3%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FLUVOXAMINE ER 150 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for FLUVOXAMINE ER 150 MG CAPSULE, manufactured by Ajanta Pharma USA Inc., is $3.6822 per EA (NDC 27241027530), effective Nov 18, 2026.

How has the price of FLUVOXAMINE ER 150 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for FLUVOXAMINE ER 150 MG CAPSULE has declined 25.3%. It has been tracked across 93 weekly CMS publications since Feb 12, 2025.

What are the highest and lowest recorded NADAC prices for FLUVOXAMINE ER 150 MG CAPSULE?

Since Feb 12, 2025, the NADAC for FLUVOXAMINE ER 150 MG CAPSULE has ranged from a low of $3.5197 (Oct 21, 2026) to a high of $5.6209 (Aug 13, 2025), with a median of $5.1609 per EA.

Are there cheaper alternatives to FLUVOXAMINE ER 150 MG CAPSULE?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FLUVOXAMINE ER 150 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures FLUVOXAMINE ER 150 MG CAPSULE?

FLUVOXAMINE ER 150 MG CAPSULE (NDC 27241027530) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.